# Azilsartan medoxomil

## Edarbi 40mg

| 藥物代碼           | OEDA                                                                                                                                                                                                                                                     |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of hypertension; may be used alone or in combination with other antihypertensives.                                                                                                                                                             |
| 副作用             | Hypotension, orthostatic hypotension, Dizziness, fatigue, Diarrhea, nausea, Decreased hemoglobin, decreased hematocrit, decreased red blood cells, leukopenia (rare), thrombocytopenia (rare), Muscle spasm, weakness, Increased serum creatinine, Cough |
| 禁忌               | Hypersensitivity to azilsartan medoxomil or any component of the formulation; concomitant use with aliskiren in patients with diabetes or moderate-to-severe renal impairment (GFR <60 mL/minute/1.73 m2).                                               |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                     |
| 用法用量           | Adult:  Initial: 40 mg once daily; may increase to 80 mg once daily if necessary.                                                                                                                                                                        |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                             |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                             |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                 |
| 孕期用藥建議       | Human data suggest risk in 2nd and 3rd trimester                                                                                                                                                                                                         |
| 附帶說明           | N/A                                                                                                                                                                                                                                                      |
| 哺乳期用藥建議     | Human Data Suggest Potential Toxicity                                                                                                                                                                                                                    |
| 附帶說明           | N/A                                                                                                                                                                                                                                                      |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                      |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                      |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                      |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                      |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                      |
| 注意事項           | N/A                                                                                                                                                                                                                                                      |

